Genetic and Biochemical Mechanisms for Bacterial Lipid A Modifiers Associated with Polymyxin Resistance

Area of Science:

• Microbiology
• Biochemistry
• Genetics

Background:

• Polymyxins are critical last-resort antibiotics against carbapenem-resistant pathogens.
• Resistance to polymyxins often arises from modifications to the bacterial lipopolysaccharide (LPS) lipid A.
• Understanding these resistance mechanisms is crucial for combating multidrug-resistant infections.

Purpose of the Study:

• To review and integrate the genetic, structural, and biochemical mechanisms of major lipid A modifiers conferring polymyxin resistance.
• To highlight specific enzymes including ArnT, EptA, and the AlmEFG system.
• To discuss the implications of the emerging mobile colistin resistance (MCR) enzymes.

Main Methods:

• Literature review integrating genetic, structural, and biochemical data.
• Analysis of lipid A modification pathways.
• Discussion of enzyme functions and their role in resistance.

Main Results:

• Identified three primary types of intrinsic polymyxin resistance mechanisms involving lipid A modification: ArnT (glycosyltransferase), EptA (phosphoethanolamine transferase), and the AlmEFG system.
• Detailed the specific roles of these enzymes in altering the bacterial surface.
• Highlighted the emergence and significance of mobile colistin resistance (MCR) enzymes, which are analogous to EptA.

Conclusions:

• Lipid A structural remodeling is a key strategy for bacterial polymyxin resistance.
• ArnT, EptA, and AlmEFG represent significant intrinsic resistance mechanisms.
• The proliferation of MCR enzymes poses a substantial threat to global public health, necessitating further research and surveillance.